This topic contains a solution. Click here to go to the answer

Author Question: The first important chinchilla mutant variety was a white male born in 1955, but it was not a true ... (Read 21 times)

K@

  • Hero Member
  • *****
  • Posts: 608
The first important chinchilla mutant variety was a white male born in 1955, but it was not a true albino because it had _____ eyes.
 A)blue
 B)red
 C)black
 D)brown

Question 2

Richard Gloek of Leipzig, the Chinchilla King, handled __________ pelts in 1901.
 A)75,000
 B)300,000
 C)25,000
 D)200,000



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mbcrismon

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

C

Answer to Question 2

B




K@

  • Member
  • Posts: 608
Reply 2 on: Jul 18, 2018
YES! Correct, THANKS for helping me on my review


ebonylittles

  • Member
  • Posts: 318
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Oxytocin is recommended only for pregnancies that have a medical reason for inducing labor (such as eclampsia) and is not recommended for elective procedures or for making the birthing process more convenient.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Adults are resistant to the bacterium that causes Botulism. These bacteria thrive in honey – therefore, honey should never be given to infants since their immune systems are not yet resistant.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library